Glessner Coleen (CIK 0001919170)

Latest company ownership

EBS - Emergent BioSolutions Inc.

Role: EVP, Quality & Ethics, and CPL

Shares held

144,319

Last filed at

Oct 16, 2025

Confidence Score

26.3

2025Q4

Confidence Score History

2024Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Oct 7, 2025	Oct 16, 2025	Emergent BioSolutions Inc.	EVP, Quality & Ethics, and CPL	Sell	17.5	-30,608	-17.50%	✓	$306.1K
Jun 8, 2025	Jun 10, 2025	Emergent BioSolutions Inc.	EVP, Quality & Ethics, and CPL	Sell	37.5	-1,249	-0.71%	✗	$8.3K
Apr 7, 2025	Apr 9, 2025	Emergent BioSolutions Inc.	EVP, Quality & Ethics, and CPL	Sell	45.0	-480	-0.27%	✗	$2.1K
Feb 12, 2025	Mar 4, 2025	Emergent BioSolutions Inc.	EVP, Quality & Ethics, and CPL	Sell	27.5	-30,304	-20.98%	✗	$2.3K
Dec 8, 2024	Dec 10, 2024	Emergent BioSolutions Inc.	EVP, Quality & Ethics, and CPL	Sell	22.5	-18,674	-11.45%	✗	$168.3K
Jun 8, 2024	Jun 11, 2024	Emergent BioSolutions Inc.	EVP, Quality & Ethics, and CPL	Sell	37.5	-1,249	-0.76%	✗	$7.7K
Apr 7, 2024	Apr 9, 2024	Emergent BioSolutions Inc.	EVP, Quality & Ethics, and CPL	Sell	45.0	-585	-0.35%	✗	$1.3K
Mar 1, 2024	Mar 4, 2024	Emergent BioSolutions Inc.	EVP, Quality & Ethics, and CPL	Sell	45.0	-381	-0.23%	✗	$1.3K